Piramal Pharma’s share price climbed dramatically on the National Stock Exchange (NSE) this week reaching 19.42% amid heavy volumes.
PPL, a part of the Piramal Group, is a global pharmaceutical firm that offers end-to-end pharma solutions to its customers through a network of development and production facilities in India, North America and the United Kingdom/Europe.
PPL functions under three business verticals: Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organisation (CDMO); Piramal Critical Care (PCC), a complex hospital generics (CHG) business; and India Consumer Healthcare (ICH), which sells over-the-counter healthcare and wellness products.
Stock Performance on Friday
– Open: ₹219.25
– High: ₹227.90
– Low: ₹218.60
